by Kim Lavine, Founder/CEO of Hypersence

Three years ago, I was lying in a hospital bed, fighting for my life after a near-fatal brain aneurysm. I was one of the lucky ones—half of people who experience one never survive. I had to relearn how to walk and talk.

It’s been a journey, but on September 17th I will return to the stage to pitch MemorySPEX® at AgeInnovate in Nashville—presenting a brain health solution millions of people have been waiting for. If you’re in Nashville, please join us. The AgeInnovate event is free and open to the public, but registration is required: https://bit.ly/AgeInnovate.

We’re pioneering the future of brain health and raising a $2.5M seed round—forecasting a multi-billion dollar exit—to launch MemorySPEX®, a patent-pending wearable that uses light and AI to improve cognitive function up to 50%—as easy as putting on a pair of glasses.

We’re entering the market competing with the $14B brain supplement category, offering a safer, more effective alternative, then filing as an FDA Class II device for the treatment of Alzheimer’s. The brain health wearable market is projected to reach $895B by 2032—and we’re positioned to lead it.

We won Stanford’s “Chairman’s Choice” award, competing with top startups from around the globe. Backing us are five doctor investor/advisors who believe we’re only at the beginning of what this technology can do—including the potential to treat autism. As the mother of an autistic son, that possibility is especially meaningful to me.

We’re currently in due diligence with a lead investor and looking for others to fill our round. Learn more in our Data Room, including a brief overview video: https://hypersence.com/investor-info, or contact me directly at kim@hypersence.com

We are in the middle of a global brain health crisis:

· Since COVID, 1 in 6 people worldwide suffer from reduced cognitive function—brain fog, memory loss, and burnout.

· 1 in 3 older adults dies with Alzheimer’s or another dementia.

· Families and healthcare systems alike are overwhelmed by the cost and lack of effective solutions.

Until now, the only widely available “answers” have been unregulated brain health supplements, offering ‘hope in a bottle,’ with little proof they work.

How does it work? Using only ambient light, MemorySPEX deliver gamma oscillations to the hippocampus and visual cortex, proven in clinical trials to clear harmful plaque accumulations and improve blood flow, improving cognitive function up to 50%. That translates into more success at work, more presence with family, and more energy to pursue the goals that matter most. In short: achieving dreams of a better life. So let me ask: what would you pay to achieve dreams of a better life?

MemorySPEX will be available for $400, plus a $20/month subscription—a fraction of the cost of supplements, therapies, or lost productivity. Join the wait list today: https://bit.ly/MemorySPEXwaitlist.

And we’re just getting started. In January 2026, we’ll officially launch MemorySPEX at CES in Las Vegas, where we’ve already been vetted for a CES Innovation Award.

On September 17th, I’ll be pitching MemorySPEX at AgeInnovate in Nashville. On January 6th, we’ll step onto the global stage at CES. This journey included a brain aneurysm—but it’s leading toward a future where millions can achieve dreams of a better life through better brain health.

Hope to see you there!
Kim Lavine